Single-Cell RNA Sequencing and Inferred Protein Activity Analysis Reveal a Distinct Tumor Phenotype in Early-Onset Colorectal Cancer Patients
Authors:
Preprint
Abstract
Colorectal cancer (CRC) diagnosed before age 50 years (early-onset CRC, EO-CRC) is rising at an alarming rate, yet its molecular and microenvironmental drivers remain poorly understood. EO-CRC is highly heterogeneous, and while subtle differences from late-onset CRC (LO-CRC) have been reported, their full extent remains unresolved due to the limited scope of previous studies. Here, we integrate public data with in-house clinical samples profiled by single-cell RNA sequencing (scRNA-seq) and multiplex immunofluorescence (mIF) to compare EO-CRC and LO-CRC. Additionally, we employ gene regulatory network-based protein activity inference (VIPER), enabling a more precise characterization of key regulatory proteins driving tumor-stroma interactions. Our analysis reveals that EO-CRC and LO-CRC have a largely similar immune composition, challenging previous reports of an “immune-cold” phenotype in EO-CRC. However, we identify distinct stromal differences, including a significant enrichment of fibroblasts in EO-CRC. Notably, we define a previously unrecognized epithelial subpopulation in EO-CRC, marked by high expression of toll-like receptor 4 (TLR4) and C-C chemokine receptor type 5 (CCR5)—key mediators of inflammation-driven tumor progression and fibroblast recruitment. These findings suggest that EO-CRC may be driven by a tumor-intrinsic inflammatory phenotype with enhanced stromagenesis, providing new insights into potential mechanisms underlying its increasing incidence in young adults.Keywords
Funding Information
- Norges Idrettshøgskole (1R38CA277850-01A1)
- Norges Idrettshøgskole (P30CA013696)
- Norges Idrettshøgskole (UL1TR001873)
This publication has 40 references indexed in Scilit:
- Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2022
- The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detectionThe Lancet Gastroenterology & Hepatology, 2022
- Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancerCancer Immunology, Immunotherapy, 2021
- Spatially organized multicellular immune hubs in human colorectal cancerCell, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophagesCell, 2021
- Direct Comparative Analyses of 10X Genomics Chromium and Smart-Seq2Genomics, Proteomics & Bioinformatics, 2021
- Early‐onset colorectal cancer in young individualsMolecular Oncology, 2018
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010JAMA Surgery, 2015
- Crucial involvement of the CCL3‐CCR5 axis‐mediated fibroblast accumulation in colitis‐associated carcinogenesis in miceInternational Journal of Cancer, 2014